Free Trial
NASDAQ:LIVN

LivaNova (LIVN) Stock Price, News & Analysis

LivaNova logo
$52.83 -0.54 (-1.01%)
As of 03:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About LivaNova Stock (NASDAQ:LIVN)

Advanced

Key Stats

Today's Range
$52.50
$54.31
50-Day Range
$41.13
$58.72
52-Week Range
$32.48
$58.91
Volume
321,734 shs
Average Volume
687,620 shs
Market Capitalization
$2.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$59.71
Consensus Rating
Moderate Buy

Company Overview

LivaNova Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

LIVN MarketRank™: 

LivaNova scored higher than 48% of companies evaluated by MarketBeat, and ranked 612th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LivaNova has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 5 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    LivaNova has a consensus price target of $59.71, representing about 12.7% upside from its current price of $52.99.

  • Amount of Analyst Coverage

    LivaNova has only been the subject of 4 research reports in the past 90 days.

  • Read more about LivaNova's stock forecast and price target.
  • Earnings Growth

    Earnings for LivaNova are expected to grow by 10.18% in the coming year, from $2.85 to $3.14 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LivaNova is -13.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LivaNova is -13.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LivaNova has a P/B Ratio of 2.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about LivaNova's valuation and earnings.
  • Percentage of Shares Shorted

    4.21% of the outstanding shares of LivaNova have been sold short.
  • Short Interest Ratio / Days to Cover

    LivaNova has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LivaNova has recently increased by 16.16%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LivaNova does not currently pay a dividend.

  • Dividend Growth

    LivaNova does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.21% of the outstanding shares of LivaNova have been sold short.
  • Short Interest Ratio / Days to Cover

    LivaNova has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LivaNova has recently increased by 16.16%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    LivaNova has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for LivaNova this week, compared to 6 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, LivaNova insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.29% of the stock of LivaNova is held by insiders.

  • Percentage Held by Institutions

    97.64% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LivaNova's insider trading history.
Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LIVN Stock News Headlines

GOLD ALERT
Gold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" Eifrig says history shows it could be on the verge of its biggest bull run in over half a century.tc pixel
LivaNova (NASDAQ:LIVN) Cut to Hold at The Goldman Sachs Group
See More Headlines

LIVN Stock Analysis - Frequently Asked Questions

LivaNova's stock was trading at $46.31 on January 1st, 2025. Since then, LIVN shares have increased by 14.4% and is now trading at $52.9850.

LivaNova PLC (NASDAQ:LIVN) issued its earnings results on Wednesday, August, 6th. The company reported $1.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.21. The firm's revenue was up 10.6% compared to the same quarter last year.
Read the conference call transcript
.

LivaNova's top institutional investors include Central Pacific Bank Trust Division (0.01%) and GAMMA Investing LLC. Insiders that own company stock include Damien Mcdonald, Daniel Jeffrey Moore and Francesco Bianchi.
View institutional ownership trends
.

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LivaNova investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/06/2025
Today
10/06/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:LIVN
CIK
1639691
Employees
2,900
Year Founded
2015

Price Target and Rating

High Price Target
$64.00
Low Price Target
$55.00
Potential Upside/Downside
+11.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.89)
Trailing P/E Ratio
N/A
Forward P/E Ratio
18.73
P/E Growth
N/A
Net Income
$63.23 million
Net Margins
-16.13%
Pretax Margin
-13.85%
Return on Equity
14.57%
Return on Assets
6.91%

Debt

Debt-to-Equity Ratio
0.31
Current Ratio
1.29
Quick Ratio
1.09

Sales & Book Value

Annual Sales
$1.25 billion
Price / Sales
2.32
Cash Flow
$4.24 per share
Price / Cash Flow
12.59
Book Value
$24.31 per share
Price / Book
2.20

Miscellaneous

Outstanding Shares
54,600,000
Free Float
54,443,000
Market Cap
$2.91 billion
Optionable
Optionable
Beta
0.95

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:LIVN) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners